☆ 4.2 Article

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections

MEDICINA-LITHUANIA (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Ophthalmology

Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration

Ramin Tadayoni et al.

Summary: This article reviews the unique molecular design of brolucizumab, a single-chain antibody fragment specifically designed for intraocular use, which allows for a higher concentration of material per intravitreal injection compared to other anti-VEGF agents. Clinical trials have shown the efficacy of brolucizumab in treating nAMD, with signals of a more durable treatment effect and the ability to be administered every 3 months to maintain disease control. The preclinical and clinical data provide evidence of sustained disease control with longer injection intervals, potentially reducing the treatment burden in nAMD patients.

OPHTHALMOLOGICA (2021)

添加到收藏夹

Article Ophthalmology

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

HAWK and HARRIER

Pravin U. Dugel et al.

OPHTHALMOLOGY (2020)

添加到收藏夹

Article Ophthalmology

Nascent Type 3 Neovascularization in Age-Related Macular Degeneration

Riccardo Sacconi et al.

OPHTHALMOLOGY RETINA (2018)

添加到收藏夹

Article Ophthalmology

Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy

Nopasak Phasukkijwatana et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2017)

添加到收藏夹

Article Ophthalmology

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT

Alexandra Miere et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)

添加到收藏夹

Article Ophthalmology

TYPE 3 NEOVASCULARIZATION IMAGED WITH CROSS-SECTIONAL AND EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Anna C. S. Tan et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)

添加到收藏夹

Article Ophthalmology

Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization

Richard F. Spaide

AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)

添加到收藏夹

Article Ophthalmology

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TYPE 3 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Laura Kuehlewein et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)

添加到收藏夹

Article Ophthalmology

Retinal Vascular Layers Imaged by Fluorescein Angiography and Optical Coherence Tomography Angiography

Richard F. Spaide et al.

JAMA OPHTHALMOLOGY (2015)

添加到收藏夹

Article Ophthalmology

The Incidence of Neovascular Subtypes in Newly Diagnosed Neovascular Age-Related Macular Degeneration

Jesse J. Jung et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)

添加到收藏夹

Article Ophthalmology

LONGITUDINAL ANATOMICAL RESPONSE OF RETINAL-CHOROIDAL ANASTOMOSIS TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

Giuseppe Querques et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

添加到收藏夹

Article Ophthalmology

Retinal angiomatous proliferation or retinal anastomosis to the lesion

A. W. Scott et al.

EYE (2010)

添加到收藏夹

Article Ophthalmology

Type 3 neovascularization - The expanded spectrum of retinal angiomatous proliferation

K. Bailey Freund et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)

添加到收藏夹

Article Ophthalmology

Retinal angiomatous proliferation in age-related macular degeneration

LA Yannuzzi et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.